Author Archives: Fei Ye

As December unfolds, DIMA, a leading biotechnology company, is gearing up for a strong presence at several esteemed international conferences. This engagement underscores DIMA’s commitment to advancing antibody research and presenting groundbreaking developments in CAR-T therapy.